FDA approves rapid MRSA/MSSA test

Share this article:
The Food and Drug Administration has approved a blood culture test that can determine if Staphylococcus aureus bacteria infections are methicillin resistant (MRSA) or methicillin susceptible (MSSA).The KeyPath MRSA/MSSA Blood Culture Test can distinguish between the diseases within approximately five hours after any bacterial growth is first detected, the agency said. This should come as good news for nursing homes, where infections among patients with weakened immune systems can be deadly and spread rapidly.
Share this article:

More in Products

Bertlesmann buys Relias Learning

Bertelsmann, a media company based in Germany, said last week it is buying Relias Learning from its current owners, Vista Equity Partners and LLR Partners.

Acuity Brands introduces LED collection

Acuity Brands introduces LED collection

Acuity Brands says its new CanoeTM LED Pendant and Sconce Collection from Winona Lighting® can meet the needs of designers in unique spaces.

SwimEx debuts Triton Pool

SwimEx debuts Triton Pool

SwimEx Inc. has announced the Triton, the newest member of its line of fitness and therapy pools. It is available for the commercial and residential markets.